Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 322

1.

Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh.

Alam S, Noor-E-Alam SM, Chowdhury ZR, Alam M, Kabir J.

World J Hepatol. 2013 May 27;5(5):281-7. doi: 10.4254/wjh.v5.i5.281.

2.

Irisin in patients with nonalcoholic fatty liver disease.

Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS.

Metabolism. 2014 Feb;63(2):207-17. doi: 10.1016/j.metabol.2013.09.013. Epub 2013 Oct 18.

PMID:
24140091
3.

Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh.

Alam S, Gupta UD, Alam M, Kabir J, Chowdhury ZR, Alam AK.

Indian J Gastroenterol. 2014 Sep;33(5):452-7. doi: 10.1007/s12664-014-0488-5. Epub 2014 Jul 15.

PMID:
25023045
4.

Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.

Ozturk O, Colak Y, Senates E, Yilmaz Y, Ulasoglu C, Doganay L, Ozkanli S, Oltulu YM, Coskunpinar E, Tuncer I.

World J Gastroenterol. 2015 Jul 14;21(26):8096-102. doi: 10.3748/wjg.v21.i26.8096.

5.

Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.

Fracanzani AL, Petta S, Lombardi R, Pisano G, Russello M, Consonni D, Di Marco V, Cammà C, Mensi L, Dongiovanni P, Valenti L, Craxì A, Fargion S.

Clin Gastroenterol Hepatol. 2017 May 26. pii: S1542-3565(17)30614-6. doi: 10.1016/j.cgh.2017.04.045. [Epub ahead of print]

PMID:
28554682
6.

[Prevalence of nonalcoholic fatty liver disease and metabolic syndrome in obese children].

Shi HB, Fu JF, Liang L, Wang CL, Zhu JF, Zhou F, Zhao ZY.

Zhonghua Er Ke Za Zhi. 2009 Feb;47(2):114-8. Chinese.

PMID:
19573457
7.
8.

Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.

Ito S, Yukawa T, Uetake S, Yamauchi M.

Alcohol Clin Exp Res. 2007 Jan;31(1 Suppl):S83-7.

PMID:
17331172
9.

Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.

Seki Y, Kakizaki S, Horiguchi N, Hashizume H, Tojima H, Yamazaki Y, Sato K, Kusano M, Yamada M, Kasama K.

J Gastroenterol. 2016 Mar;51(3):281-9. doi: 10.1007/s00535-015-1114-8. Epub 2015 Aug 28.

PMID:
26314837
10.

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA.

Gastroenterology. 2011 Jan;140(1):124-31. doi: 10.1053/j.gastro.2010.09.038. Epub 2010 Sep 19.

PMID:
20858492
11.

Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort.

Kashyap SR, Diab DL, Baker AR, Yerian L, Bajaj H, Gray-McGuire C, Schauer PR, Gupta M, Feldstein AE, Hazen SL, Stein CM.

Obesity (Silver Spring). 2009 Sep;17(9):1696-701. doi: 10.1038/oby.2009.89. Epub 2009 Apr 9.

12.

Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease.

Tarantino G, Scopacasa F, Colao A, Capone D, Tarantino M, Grimaldi E, Savastano S.

World J Gastroenterol. 2011 Dec 28;17(48):5280-8. doi: 10.3748/wjg.v17.i48.5280.

13.

Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Eslami L, Merat S, Malekzadeh R, Nasseri-Moghaddam S, Aramin H.

Cochrane Database Syst Rev. 2013 Dec 27;(12):CD008623. doi: 10.1002/14651858.CD008623.pub2. Review.

PMID:
24374462
14.

Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.

Liew PL, Lee WJ, Wang W, Lee YC, Chen WY, Fang CL, Huang MT.

Obes Surg. 2008 Jul;18(7):847-53. doi: 10.1007/s11695-007-9355-0. Epub 2008 May 6.

PMID:
18459024
15.

Noninvasive estimation of disease activity and liver fibrosis in nonalcoholic fatty liver disease using anthropometric and biochemical characteristics, including insulin, insulin resistance, and 13C-methionine breath test.

Korkmaz H, Unler GK, Gokturk HS, Schmidt WE, Kebapcilar L.

Eur J Gastroenterol Hepatol. 2015 Oct;27(10):1137-43. doi: 10.1097/MEG.0000000000000407.

PMID:
26049707
16.

Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines.

Jamali R, Arj A, Razavizade M, Aarabi MH.

Medicine (Baltimore). 2016 Feb;95(5):e2630. doi: 10.1097/MD.0000000000002630.

17.

[Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?].

Graffigna MN, Belli SH, de Larrañaga G, Fainboim H, Estepo C, Peres S, García N, Levalle O.

Acta Gastroenterol Latinoam. 2009 Mar;39(1):30-7. Spanish.

PMID:
19408737
18.

Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease.

Sonmez A, Nikolic D, Dogru T, Ercin CN, Genc H, Cesur M, Tapan S, Karslioğlu Y, Montalto G, Banach M, Toth PP, Bagci S, Rizzo M.

J Clin Lipidol. 2015 Jul-Aug;9(4):576-82. doi: 10.1016/j.jacl.2015.03.010. Epub 2015 Apr 4.

PMID:
26228676
19.

Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease.

Pacifico L, Bezzi M, Lombardo CV, Romaggioli S, Ferraro F, Bascetta S, Chiesa C.

World J Gastroenterol. 2013 Jul 7;19(25):4007-14. doi: 10.3748/wjg.v19.i25.4007.

20.

[Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis].

Yang M, Liu Y, Zhou G, Guo X, Zou S, Liu S, Jiang L, Liu Y, Zhu L, Guo C, Zhao J.

Zhonghua Gan Zang Bing Za Zhi. 2016 Feb;24(2):96-101. doi: 10.3760/cma.j.issn.1007-3418.2016.02.005. Chinese.

PMID:
26983475

Supplemental Content

Support Center